If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com).  The website is updated approximately twice a month.

PDP Press Releases/ statements

IAVI

• 4 Apr: Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

IVCC

 • 17 Apr: New Nets Prevent 13 Million Malaria Cases in Sub-Saharan Africa

TB Alliance

 • 24 Mar: Commitment, Innovation and Action are Needed to End TB — On World TB Day, We Reaffirm our Dedication to all Impacted by Tuberculosis

 • 25 Mar: Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB

 • 25 Mar: New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World

EVI

 • 24 Mar: World Tuberculosis Day 2024– We can End TB!

GARDP 

 • 24 Apr: GARDP to present positive phase 3 trial results for zoliflodacin at ESCMID Global 2024

PATH

• 25 Mar: PATH concerned about funding cuts to global health security in US budget deal

• 25 Mar: New partnership aims to improve immunization efforts in conflict-afflicted and under immunized settings

MMV

• 17 May: MMV and GSK win Society of Chemical Industry Innovation Award

• 24 Apr: MMV unveils its 2024–2030 business plan at MIM Society Conference, Rwanda

• 24 Apr: Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria

• 25 Apr: The Australian Government announces funding for MMV

DNDi

• 9 May: DNDi welcomes GHIT Fund’s renewed support to optimize novel compounds to treat Chagas disease

• 23 Apr: Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia

FIND

•  5 Apr: New £6.2M partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya

•  5 Apr: Global deployment of rapid diagnostic tests to boost fight against cholera

IVI

• 8 May: International Vaccine Institute, Baylor College of Medicine, and Regional Center for Innovation in Vaccines and Biopharmaceuticals AIP exchange an MOU to advance global health research and capability

• 20 Mar: IVI starts technology transfer to Biological E. Limited to manufacture oral cholera vaccine for India and global markets

Population Council

• 20 Feb: The Population Council’s Center for Biomedical Research enters agreement with Exeltis to develop a non-hormonal multipurpose intravaginal ring

PDP Funder Announcements

• 6 May: Novo Nordisk Foundation, Wellcome, and the Gates Foundation join forces to accelerate global health equity and impact. Wellcome

• 6 May: Industry Engagement Forum in Lagos aims to increase health product manufacturing in Africa. Unitaid

• 9 May: Approximately USD10.8 million invested in new drug development for malaria and NTDs in partners including Japanese pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-based institutions. GHIT

• 15 May: EU funded Global Health EDCTP3 mobilises emergency funding to tackle the Mpox outbreak in the DRC and beyond; call for proposals closing 29 May. EU

• 16 May: £85 million pledged to tackle antibiotic emergency. UK Government

• 25 Apr: UK improves access to life-saving malaria drugs. UK Government

Funder Announcement Archives

     •     2014 PDP Funder Announcements

     •     2013 PDP Funder Announcements

New PDP Publications

•  25 Apr: Rethinking antibodies for infectious diseases?. IAVI

Other Reports/ Publications

• Mar 5: 2023 TB Pipeline Report. TAG

• Mar 14: Doing Well by Doing Good: Why Investing in Global Health R&D Benefits the United States and the World. GHTC

Related Press Releases/ Announcements/ non-Peer Reviewed Articles

• 1 May: Why Africa is facing an uphill battle to make its own vaccines. The Telegraph

• 1 May: Moderna Cancels Kenya Vaccine Project Due to Familiar Economic Hurdles. Think Global Health

• 1 Apr: New report on HIV drug resistance: Challenges and recommendations. News Medical

• 2 May: Political tensions weaken battle against biggest diseases, warns health charity chief. Financial Times

• 2 May: Groups call for 'actionable steps' to address antimicrobial resistance. CIDRAP

• 2 May: The harsh reality of multidrug resistant TB in children. Devex

• 2 May: Deeper understanding of malaria parasite development unlocks opportunities to block disease spread. Science Daily

• 2 Apr: From equitable access to equitable innovation: rethinking bioengineering for global health. Nature Bioengineering

• 2 Apr: New malaria vaccine strain shows promise in preclinical trials. News Medical

• 2 Apr: Advances in HIV treatment for adolescents: Are long-acting injectables the future?. Healio

• 2 Apr: Bavarian Nordic announces commercial launch of mpox vaccine. CIDRAP

• 2 Apr: Expanding Access to Long Acting HIV Prevention and Treatment Through Mobile Pharmacies. O’Neil Institute

• 3 Apr: Health As a Driver of Innovation Not Just a Recipient. Health Policy Watch

• 3 Apr: How the next wave of vaccines could target human parasites. Gavi

• 3 Apr: Experimental Ebola vaccines found safe and capable of producing immune responses in healthy adults. NIAID Blog

• 3 Apr: As AI proliferates, biopharma companies seek to harness it in clinical trials. STAT

• 3 Apr: New discovery unravels malaria invasion mechanism. Phys.org

• 3 May: ‘Get it Done’ or Don’t Block Consensus, Tedros Urges Pandemic Agreement Negotiators. Health Policy Watch

• 3 May: Data arms Africa’s fight against malaria. Gavi

• 3 Apr: Interventions to address antimicrobial resistance: an ethical analysis of key tensions and how they apply in low- income and middle-income countries. BMJ Global Health

• 4 Apr: Will the Gates Foundation’s preprint-centric policy help open access?. Nature

• 4 Apr: First-generation malaria vaccine successfully implemented in three African countries. The Lancet

• 4 Apr: Feasibility, safety, and impact of the RTS,S/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi. The Lancet

• 4 Apr: Drug prices soar after pharma giants GSK and Sanofi exit Nigeria. Devex

• 4 Apr: Thinking beyond diagnostic accuracy to evaluate tuberculosis screening tests. The Lancet Global Health

• 4 Apr: Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study. The Lancet Global Health

• 4 Apr: Tuberculosis screening in adults with HIV: beyond symptoms. The Lancet Global Health

• 4 Apr: Climate change: A driver of increasing vector-borne disease transmission in non-endemic areas. PLOS Medicine

• 4 Apr: Eight recommendations to shape the future of immunisation. Gavi

• 4 Apr: Tinubu to Gavi CEO: Nigerian manufacturers capable, ready to produce vaccines. Vanguard News

• 4 May: Chikungunya crisis in the Americas: a comprehensive call for research and innovation. The Lancet

• 5 Apr: India’s newly amended patent rules threaten affordable medicines in the Global South. People’s Dispatch

• 6 May: BARDA launches diagnostics, medical devices accelerator. 360Dx

• 6 May: Asymptomatic parasitemia and RTS,S vaccine efficacy. Lancet Infectious Diseases

• 6 May: Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial. Lancet Infectious Diseases

• 6 May: Scientists create vaccine with potential to protect against future coronaviruses. The Guardian

• 6 May: Leveraging malaria vaccines and mRNA technology to tackle the global inequity in pharmaceutical research and production towards disease elimination. Malaria Journal

• 6 May: Global health heavyweights team up for climate, disease funding. Reuters

• 6 May: WHO Africa Advances African Science by Promoting Peer-Reviewed Research. IPS

• 7 May: WHO’s top scientist learned a hard lesson about H5N1 two decades ago: Stopping it takes more than biology. STAT

• 7 May: Exclusive: Africa CDC audit warns against creating an 'avenue for fraud'. Devex

• 7 May: Antibody reduces risk of malaria in children. NIH Research Matters

• 7 May: Is the African Vaccine Manufacturing Accelerator a decoupling mechanism?. International Health

• 7 May: World’s Three Largest Health Philanthropies Join Forces in $300 Million Initiative to Support Innovation in Developing Countries. Health Policy Watch

• 8 May: Enhancing capacity for malaria vaccine introduction and rollout in Africa through experience sharing. WHO

• 8 May: Global effort aims to protect health and safety of human ‘guinea pigs’ in drug trials. Science

• 8 May: Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study. The Lancet Infectious Diseases

• 8 May: Rapid diagnostic tests for Lassa fever: what do we aim for?. The Lancet Infectious Diseases

• 8 May: Urgent considerations for booster vaccination strategies against Ebola virus disease. The Lancet Infectious Diseases

• 8 May: WHO Publishes Six Country Case Studies on Local Production Ecosystems for Pharmaceuticals, Vaccines, and Biologicals. WHO

• 8 May: Future pandemics will have the same human causes as ancient outbreaks − lessons from anthropology can help prevent them. Gavi

• 9 May: Notice of Collaboration Agreement for the Discovery and Development of Novel Malaria Preventive Drugs with Nagasaki University, National Institute of Infectious Diseases, and MMV, Supported by the GHIT Fund. Shinogi

• 9 May: Ghana: Enhancing Capacity For Malaria Vaccine Introduction And Rollout In Africa Through Experience Sharing. Africa.com

• 9 May: As Consensus on Pandemic Agreement by Deadline Looks Impossible, What Are the Options?. Health Policy Watch

• 9 May: The surge of mpox in Africa: a call for action. The Lancet

• 9 May: Access to medical technology saves lives. How can we make it more accessible in low- and middle-income countries?. World Bank

• 9 May: Korea & America join hands to advance global health research and capability. BioSpectrum Asia

• 9 May: Decolonising global health: why the new Pandemic Agreement should have included the principle of subsidiarity. The Lancet Global Health

• 10 May: Governments agree to continue their steady progress on proposed pandemic agreement ahead of the World Health Assembly. WHO

• 10 May: WHO Member States Miss Deadline for Agreement on Pandemic Accord, But Agree to Soldier On in Next Two Weeks. Health Policy Watch

• 10 May: A century after the first TB vaccine, a new vaccine is reigniting hope. Gavi

• 10 Apr: Oxford University and Brazil partner to advance malaria vaccine development. News Medical

• 11 Apr: 'World’s most comprehensive' health database opens to LMIC researchers. Devex

• 11 Apr: Is brain drain limiting Africa’s genomics potential?. Devex

• 11 Apr: Ending “domestic helicopter research”. Science Direct

• 11 Apr: Moderna puts plans for African vaccine plant on hold. The Financial Times

• 11 Apr: African Nations Have Agreed A Plan To Increase Locally Produced Vaccines. This Is How It Will Work. Africa.com

• 11 Apr: Exclusive: Concerned About an Unrealistic Deadline to Conclude a Pandemic Agreement, Some Countries Now Seek an Alternative Face-Saving Solution. Geneva Observer

• 11 May: GHIT Fund announces investment of approximately US$ 10.8 million in new drug development for malaria and neglected tropical diseases. PharmaBiz

• 11 Apr: The push for a better dengue vaccine grows more urgent. The New York Times

• 11 Apr: Facing uncertain vaccine demand, Moderna halts mRNA plant buildout in Kenya. Fierce Pharma

• 11 Apr: In world first, Nigeria introduces new 5-in-1 vaccine against meningitis. WHO

• 11 Apr: A new tool for accelerating tuberculosis vaccine development. The Lancet Infectious Diseases

• 12 Apr: Expanding options of child-friendly, single-tablet regimens for young children with HIV. The Lancet HIV

• 12 Apr: In world first, Nigeria introduces new 5-in-1 vaccine against meningitis. WHO

• 12 Apr: Asia-Pacific gets new weapon in fight against drug-resistant TB. France 24

• 12 May: Hesitancy towards R21/Matrix-M malaria vaccine among Ghanaian parents and attitudes towards immunizing non-eligible children: a cross-sectional survey. Malaria Journal

• 13 May: Malaria vaccine: WHO position paper. WHO

• 13 May: Next-Gen malaria jabs can achieve WHO strategic goal. The Nation

• 13 May: Rise of drug-resistant superbugs could make Covid pandemic look ‘minor’, expert warns. The Guardian

• 13 May: How Africa is moving towards a homegrown response to health emergencies. Gavi

• 13 May: Melinda French Gates resigns from Bill & Melinda Gates Foundation. Devex

• 15 Apr: Facilitating the development of urgently required combination vaccines. The Lancet Global Health

• 15 Apr: Principles to Guide the Pathogen Access-and-Benefit Sharing System [PABS] in a Pandemic Agreement; Update: Proposal to Buy More Time to Operationalize PABS by May 2026. Geneva Health Files

• 14 May: There might be stockpiles, but making an effective bird flu vaccine won’t be quick or easy. The Telegraph

• 14 May: Trial of Super-Vaccine Against Coronaviruses Expected in 2025. Health Policy Watch

• 14 May: From resistance to resilience: what could the future antibiotic pipeline look like?. IFPMA

• 15 May: WHO prequalifies new dengue vaccine. WHO

• 15 May: Latest Pandemic Agreement Draft Shows Progress – And a Long Way to Go. Health Policy Watch

• 15 May: Opinion: UNGA should address TB and antimicrobial resistance together. Devex

• 15 May: Socio-economic inequalities drive antimicrobial resistance risks. Here's how – and how to curb it. WEF

• 15 May: Report calls for 'urgent action' to boost antibiotic pipeline. CIDRAP

• 16 May: GSK to become a founding partner of Fleming Initiative to fight antimicrobial resistance (AMR). GSK

• 16 May: AI reveals critical gaps in global antimicrobial resistance research. Phys.org

• 16 May: Shifting patterns and competing explanations for infectious disease priority in global health agenda setting arenas. Health Policy & Planning

• 16 May: Global fight intensifies against superbug ‘menace’. Financial Times

• 16 May: UK plan to tackle rise in superbugs criticised as ‘words not action’ by major charity. The Telegraph

• 16 May: Antimicrobial resistance is a leading cause of global deaths. Now is the time to act. WEF

• 17 Apr: GSK announces promising data for gonorrhea treatment. CIDRAP

• 17 Apr: Second-generation mosquito nets prevented 13 million malaria cases in large pilot programs. STAT

• 17 May: Six things you need to know about how vaccines can help prevent antimicrobial resistance. Gavi

• 17 Apr: Latest Pandemic Agreement Draft Keeps Equity Hopes Alive – But Defers Key Operational Decisions. Health Policy Watch

• 18 Apr: CARB-X funds development of rapid, affordable gonorrhea test. CIDRAP

• 18 Apr: Gavi and UNICEF welcome approval of new oral cholera vaccine. Gavi

• 18 Apr: Chris Oyakhilome: Nigerian pastor pushing malaria vaccine conspiracy theories. BBC

• 18 Apr: New types of mosquito bed nets could cut malaria risk by up to half, trial finds. The Guardian

• 18 Apr: Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem. The New York Times

• 18 Apr: Pandemic Negotiations: ‘Hopeful and Scary Times’. Health Policy Watch

• 18 Apr: Drugs that aren’t antibiotics can also kill bacteria − new method pinpoints how. Gavi

• 18 Apr: Here’s what the pandemic treaty could achieve in May. Devex

• 18 Apr: New pandemic plan’s a lot like the old one. Politico

• 18 Apr: Bacteria found in mosquito guts could help scientists fight dengue, Zika. Science

• 18 Apr: After coming up short in COVID, Valneva focuses on chikungunya vaccine launch. Fierce Pharma

• 18 Apr: The path to a better tuberculosis vaccine runs through Montana. KFF News

• 19 Apr: Will new global health rules help make the world safer?. Devex

• 19 Apr: Bed Nets Treated With Two Insecticides Instead of One Are Much More Effective Against Malaria. Health Policy Watch

• 19 Apr: Pressure Builds On Countries To Embrace Weak Pandemic Agreement, Operationalizing Equity at Risk with a Framework Approach. Geneva Health Files

• 20 Apr: Next pandemic likely to be caused by flu virus, scientists warn. The Guardian

• 20 Apr: The Implementation of a Malaria Vaccine in Cameroon. Borgen Magazine

• 22 Apr: Two new malaria vaccines are being rolled out across Africa: how they work and what they promise. The Conversation

• 22 Apr: Opinion: Why the silence on the shortfall in malaria vaccine doses?. Devex

• 22 Apr: Sierra Leone anticipates imminent immunisation campaign against malaria, the country’s number one child killer. Gavi

• 22 Apr: Praise and Criticism as Talks to Amend International Health Rules Near Conclusion. Health Policy Watch

• 22 Apr: R21/Matrix-M malaria vaccine: Evidence to recommendations framework, 2023. WHO

• 22 Apr: Evidence to Recommendation table: RTS,S/AS01 Malaria Vaccine, 2023. WHO

• 23 Apr: New antibiotics aren’t being fully used, study finds. CIDRAP

• 23 Apr: Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia. The National Tribune

• 23 Apr: A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial. BMC Medicine

• 23 Apr: Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show. News Medical

• 23 Apr: “I’ve had enough of witnessing despair”: relief and hope greet Benin’s malaria vaccine roll-out. Gavi

• 23 Apr: Evaluation of Segmentation, Rotation, and Geographic Delivery Approaches for Deployment of Multiple First-Line Treatment (MFT) to Respond to Antimalarial Drug Resistance in Africa: A Qualitative Study in Seven Sub-Sahara Countries. Tropical Medicine & Infectious Disease

• 24 Apr: R21 anti-malaria vaccine is a game changer: scientist who helped design it reflects on 30 years of research, and what it promises. The Conversation

• 24 Apr: Liberia Launches Anti-Malaria Vaccine for Children 5-18 Months Today. All Africa

• 24 Apr: Researchers lead community engagement meeting on HIV vaccine discovery. CHIMPReports

• 24 Apr: Decolonising global health research: Shifting power for transformative change. PLOS Global Public Health

• 24 Apr: I study how genomics and the environment influence the spread of malaria. Nature

• 24 Apr: Big shots: Five vaccines in development to watch in 2024. GHTC

• 24 Apr: Massive amounts of H5N1 vaccine would be needed if there’s a bird flu pandemic. Can we make enough?. STAT

• 24 Apr: Africa CDC launches initiatives to advance molecular diagnostics and genomic surveillance in Africa. Africa CDC

• 24 Apr: MSU team creates a promising vaccine candidate for antibiotic-resistant bacteria. News Medical

• 24 Apr: Opinion: This may be our last chance to halt bird flu in humans, and we are blowing it. The New York Times

• 24 Apr: Congo Republic declares mpox epidemic. Reuters

• 24 Apr: WHO redefines airborne transmission: what does that mean for future pandemics?. Nature

• 25 Apr: Climate change is bringing malaria to new areas. In Africa, it never left. The Washington Post

• 25 Apr: Malaria is still killing people in Kenya, but a vaccine and local drug production may help. ABC News

• 25 Apr: Malaria research efforts converge at the Doherty Institute. The Doherty Institute

• 25 Apr: Two new malaria vaccines are being rolled out across Africa — how they work and what they promise. The Hindu

• 25 Apr: Willingness to accept malaria vaccines amongst women presenting at outpatient and immunization clinics in Enugu state, Southeast Nigeria. Malaria Journal

• 25 Apr: Kenya: Local anti malaria drug production signals progress. Africa News

• 25 Apr: Malaria fight: Scientists shift focus to vaccine, GMO mosquitoes. The Monitor

• 25 Apr: Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir. Health Policy Watch

• 25 Apr: Unlocking the Potential of Pharmacogenomics in Africa. Health Policy Watch

• 25 Apr: Vaccines are a glimmer of hope against malaria, but the battle has only just begun. The Telegraph

• 25 Apr: Major step in malaria prevention as three West African countries roll out vaccine. WHO

• 25 Apr: How Innovative Partnerships Accelerated Access to New Malaria Tools. Think Global Health

• 25 Apr: Three More African Nations Roll Out Malaria Vaccine. Barron’s

• 25 Apr: How Innovative Partnerships Accelerated Access to New Malaria Tools. Think Global Health

• 25 Apr: Could humankind eliminate malaria for good?. Devex

• 25 Apr: In precedent-setting move towards drug-development cost transparency, MSF reveals cost of its landmark TB clinical trial: €34 million. MSF

• 25 Apr: Malaria experts call for action on growing drug resistance in Africa. Gavi

• 25 Apr: Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial. The Lancet Infectious Diseases

• 25 Apr: Lessons for dengue vaccines from a human challenge study. The Lancet Infectious Diseases

• 25 Apr: Major step in malaria prevention as three West African countries roll out vaccine. Gavi

• 25 Apr: Harnessing the potential of African youth for transforming health research in Africa. Globalisation & Health

• 25 Apr: Cost of developing new drugs may be far lower than industry claims, trial reveals. The Guardian

• 25 Apr: FHI 360 and partners introduce injectable HIV prevention method as part of research study. FHI 360

• 25 Apr: How Rwanda is fighting malaria in a lab. Devex

• 26 Apr: Experimental NIH malaria monoclonal antibody protective in Malian children. NIH

• 26 Apr: Monoclonal antibody offers strong malaria protection in children. CIDRAP

• 26 Apr: The difference a vaccine can make. Gavi

• 26 Apr: India-UK vaccine partnership helps fight malaria in African countries. The Week

• 26 Apr: The Quest for Transformative Tools to Eradicate Malaria. NEJM

• 26 Apr: WHO Group is ‘Very Close’ But Fails to Agree on Changes to International Health Regulations. Health Policy Watch

• 26 Apr: DRC is seeing its worst mpox outbreak — but has no vaccines or treatments yet. Why?. NPR

• 27 Apr: Moderna stalls on African vaccine manufacturing plans. The Lancet

• 27 Apr: Positive-unlabeled learning identifies vaccine candidate antigens in the malaria parasite Plasmodium falciparum. Nature

• 28 Apr: Final Pandemic Agreement Talks Start Amid Gamble on Process and African Show of Unity. Health Policy Watch

• 29 Apr: Climate change highlights risk of malaria resurgence. Financial Times

• 30 Apr: More African Countries Roll Out Malaria Vaccine, While Babies Get New Treatment Formulation. Health Policy Watch

Upcoming Meetings/  Webinars

--------------------------